Navigation Links
Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/3/2009

Interest income and other, net 33,935 411,352 308,973 1,426,386 ------ ------- ------- --------- Net loss $(9,406,247) $(9,188,183) $(32,655,640) $(25,181,525) =========== =========== ============ ============ Basic and diluted net loss per share $(0.28) $(0.31) $(1.01) $(0.89) ====== ====== ====== ====== Shares used to compute basic and diluted net loss per share 33,103,345 29,253,693 32,250,194 28,377,733 ========== ========== ========== ========== Optimer Pharmaceuticals, Inc. Condensed Consolidated Balance Sheets September 30, December 31, 2009 2008 ---- ---- (unaudited) ASSETS Current assets: Cash and cash equivalents $19,240,782 $16,778,880 Short-term investments 23,243,958 22,547,515 Prepaid expenses and other current assets 579,134 744,670 ------- ------- Total current assets 43,063,874 40,071,065 Property and equipment, net 697,328 694,183 Long-term investments 882,000 1,032,000 Other assets 498,644 498,250 ------- ------- Total assets $45,141,846 $42,295,498
'/>"/>
SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Optimer Pharmaceuticals to Present at September 2009 Investor Conferences
2. Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting
3. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
4. Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference
5. Optimer Pharmaceuticals to Present at June 2009 Investor Conferences
6. Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
7. Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
8. ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
9. Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update
10. OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
11. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... 2015 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has been informed that Magnum ... owned by Mr. Yuen Kam, chairman of the board ... shares (the "Shares") of  Excellent China Healthcare Investment Limited ...
(Date:8/26/2015)... ... August 26, 2015 , ... The 2015 Epigenomics & ... stem cell technology start-up company Asymmetrex to share the first report on ... a new biomarker for counting adult tissue stem cells. , With a name like ...
(Date:8/25/2015)... Aug. 25, 2015 Human Longevity, Inc. (HLI), the ... has joined the company as Chief Operating Officer. Winham, ... operations and technical experience, will report directly to HLI,s CEO, ... this new role as COO, Winham will be responsible for ... well as all facility operations. HLI currently has three locations ...
(Date:8/25/2015)... Aug. 25, 2015 Doximity, the leading ... physicians, today launched its second annual Residency ... the next generation of doctors research and compare ... percent of all senior medical students used Doximity ... as new physicians. The new Residency Navigator brings ...
Breaking Biology Technology:China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 3Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 4Human Longevity, Inc. Hires Life Sciences Leader, Mark Winham, as Chief Operating Officer 2Doximity Releases 2015-2016 Residency Navigator 2Doximity Releases 2015-2016 Residency Navigator 3
... Receives $249,500 in Additional Financing, YONKERS, N.Y., ... Board: ADVR), announced today that it has,commenced a ... healing., The Phase IIb trial is being ... Germany, led by Eckhart Kampgen, M.D.,Associate Professor for ...
... Pharma (N30), a,biopharmaceutical company focused on the discovery, ... bioavailability,announced today that it has completed a financing ... use proceeds from this financing to advance its ... and preclinical,research in the area of small molecule ...
... Fund Up to $25 Million to Advance P-552, ... Kainos,Medicines, Inc. today announced that they have entered into ... P-552,for the treatment of dry mouth associated with primary ... collaborate in the clinical,development of P-552. Kainos will provide ...
Cached Biology Technology:Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123 2Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123 3N30 Pharma Announces Financing, Expansion of Board 2Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment 2Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment 3
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics Inc. ... human interface solutions, today announced collaboration with Microsoft ... Windows 10. Microsoft leveraged Synaptics, deep expertise in ... system. Through stringent testing, Synaptics, ... certified with Microsoft,s Precision TouchPad (PTP) specification empowering ...
(Date:8/4/2015)... 04, 2015 ... announced the addition of the "Digital ... Service), Sub-Segment (Computer Forensics, Network Forensics, Mobile ... Service, Vertical and Region - Global Forecast ... By Component (Hardware, Software, and ...
(Date:7/31/2015)... 2015 BGI llevará a cabo la 10ª Conferencia ... 25 de octubre de 2015, en Shenzhen, ... décimo aniversario este año. Desde su inauguración en 2006, ... anuales más influyentes del mundo en los campos de ... más dinámicas, entusiastas y amenas. ICG-10 se ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... ports, a public enemy has infiltrated the nation's borders. Taken ... University expert, the adult female alien is the only one ... , The discovery of a single specimen of Sirex noctilio ... nation because the invasive insect species has devastated up to ...
... strains of leprosy-causing bacteria has revealed some surprises about ... across the continents by human migrations. The research, led ... in the 13 May issue of the journal Science, ... findings indicate that the world's existing leprosy infections are ...
... happen - you being in a car wreck or being bitten ... killers win a free trip to the beach. It's really no ... in a wreck are far greater than being a shark's lunch, ... has studied sharks for years. , Worldwide, about one million people ...
Cached Biology News:Alien woodwasp, threat to US pine trees, found in N.Y. 2Leprosy genome tells story of human migrations, French researchers report in Science 2Leprosy genome tells story of human migrations, French researchers report in Science 3Shark attack worries? Driving to the beach is more deadly 2